Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Cellebrite DI Ltd. (CLBT) has a Wall Street consensus price target of $20.67, based on estimates from 8 covering analysts. With the stock currently trading at $13.34, this represents a potential upside of +54.9%. The company has a market capitalization of $3.26B.
Analyst price targets range from a low of $18.00 to a high of $23.00, representing a 24% spread in expectations. The median target of $21.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CLBT trades at a trailing P/E of 43.0x and forward P/E of 36.3x. The forward PEG ratio of 0.62 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +18.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $6.47, with bear and bull scenarios of $10.21 and $368.25 respectively. Model confidence stands at 69/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CLBT stacks up against sector leader NVIDIA Corporation.
Start ComparisonThe consensus Wall Street price target for CLBT is $20.67, representing 54.9% upside from the current price of $13.34. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CLBT has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $20.67 implies 54.9% upside from current levels.
At a forward P/E of 36.25x, CLBT trades at a premium valuation. The consensus price target of $20.67 (54.9% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $23 for CLBT, while the most conservative target is $18. The consensus of $20.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $368 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CLBT is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CLBT stock forecast based on 8 Wall Street analysts shows a consensus price target of $20.67, with estimates ranging from $18 (bear case) to $23 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $6, with bear/bull scenarios of $10/$368.
Our quantitative valuation model calculates CLBT's fair value at $6 (base case), with a bear case of $10 and bull case of $368. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 69/100.
CLBT trades at a forward P/E ratio of 36.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 43.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CLBT, with a "Buy" consensus rating and $20.67 price target (54.9% upside). 8 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CLBT analyst price targets range from $18 to $23, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $20.67 consensus represents the middle ground. Our model's $10-$368 range provides an independent fundamental perspective.